Table 5 Differences in BSI caused by Gram positive and Gram negative bacteria, and between MDRs and non-MDRs
Variables | Number | Antibiotic resistance | |||
|---|---|---|---|---|---|
MDRs (n = 40) | Non-MDRs (n = 49) | Odds ratio (95 % CI) | p value | ||
Univariate analysis | |||||
Male gender | |||||
Yes | 55 | 23 | 32 | 0.72 (0.31–1.69) | 0.450 |
No | 34 | 17 | 17 | ||
Age (± SD) | 24.05 ± 2.41 | 31.09 ± 3.32 | 0.21 (0.19–0.79) | <0.001 | |
Paediatric patients | |||||
Yes | 58 | 20 | 38 | 0.29 (0.11–0.72) | 0.007 |
No | 31 | 20 | 11 | ||
Cancer type | |||||
Leukemia | 32 | 14 | 18 | 0.93 (0.9–2.21) | 0.862 |
Lymphoma | 15 | 7 | 8 | 1.08 (0.35–3.30) | 0.887 |
Myeloma | 4 | 1 | 3 | 0.39 (0.04–3.93) | 0.624 |
Solid cancer | 10 | 4 | 6 | 0.79 (0.21–3.04) | 1 |
Undiagnosed | 26 | 12 | 14 | 1.07 (0.43–2.68) | 0.887 |
Haematologic cancers | |||||
Yes | 31 | 23 | 3.89 (1.53–9.86) | 0.003 | |
No | 9 | 26 | |||
Febrile neutropenia | 21 | 10 | 11 | 1.15 (0.43–3.07) | 0.778 |
Others | 68 | 30 | 38 | ||
Year of infection | |||||
2010 | 18 | 8 | 10 | 0.97 (0.34–2.76) | 1 |
2011 | 29 | 16 | 15 | 1.51 (0.63–3.63) | 0.353 |
2012 | 31 | 17 | 14 | 1.84 (0.76–4.46) | 0.17 |
2013 | 11 | 5 | 6 | 1.02 (0.29–3.63) | 1 |
Patient location | |||||
Child health | 46 | 20 | 26 | 0.86 (0.38–2.04) | 0.778 |
Haematology | 25 | 12 | 13 | 1.18 (0.47–2.99) | 0.718 |
Others | 15 | 7 | 8 | 1.08 (0.36–3.31) | 0.887 |
CTX resistance | 0.001 | ||||
Yes | 40 | 26 | 14 | 4.64 (1.89–11.39) | |
No | 49 | 14 | 35 | ||
Gram negatives | |||||
Yes | 49 | 34 | 15 | 12.8 (4.45–37.05) | <0.001 |
No | 40 | 6 | 34 | ||
Enterobactericeae | |||||
Yes | 32 | 28 | 4 | 26.2 (7.70–89.44) | <0.001 |
No | 57 | 12 | 45 | ||
Pseudomonads | |||||
Yes | 10 | 0 | 10 | – | 0.004 |
No | 79 | 40 | 39 | ||
Multivariate factor(s) | |||||
Enterobacteriaceae | 33.6 (6.41–88.73) | <0.001 | |||